This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
Musings from The Power List: Dajun Yang
The Ascentage Pharma CEO on why next-generation small molecules are expanding into territory once reserved for biologics
09/15/2026
4 min read
Interview
